 Product Service News
August 20, 2024
In an era where businesses are increasingly looking to leverage technology for competitive advantage, Rackspace Technology is positioning itself as a critical player by delivering innovative solutions that integrate open-source offerings, artificial intelligence, and strategic collaborations. The recent launch of it...
|
Business Update
August 20, 2024
BRIDGEWATER, N.J. Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has achieved a significant milestone that promises to enhance clinical practices in the administration of anesthesia. The U.S. Food and Drug Administration (FDA) has granted Abbreviated New Drug Application (ANDA) approval for Amneal s Propofol Injec...
|
Announcement
August 20, 2024
FutureFuel Corp. Undergoes Leadership Changes Amidst Legal Challenges In a significant shift for FutureFuel Corp. (NYSE: FF), a prominent player in the manufacturing of custom and performance chemicals and biofuels, the company has appointed Roeland Polet as its new Chief Executive Officer, effective September 3, 20...
|
|
 Business Update
August 20, 2024
In a significant stride for Voya Financial, the firm has announced a momentous milestone, surpassing $100 billion in assets across multiple employer solutions. This achievement not only underscores Voya s strategic focus on servicing employer needs through Multiple Employer Plans (MEPs), Pooled Employer Plans (PEPs)...
 Product Service News
August 20, 2024
Actuate Therapeutics to Ring the Nasdaq Opening Bell on August 23, 2024, Marking a New Chapter in Biopharmaceutical Innovation CHICAGO and FORT WORTH, Texas In a significant milestone for the biopharmaceutical community, Actuate Therapeutics, Inc. (NASDAQ: ACTU) is set to ring the Nasdaq Stock Market opening bell ...
|
|
Our most Popular Articles
|
Partnership
March 19, 2025
Beam Global and Zero Motorcycles Join Forces to Promote Sustainable Solutions at MotoGP and TEVCON Events In an increasingly environmentally-conscious world, the collaboration between Beam Global and Zero Motorcycles is setting a precedent for sustainability in the motorsports industry. During the upcoming MotoGP an...
|
Product Service News
November 9, 2024
Breakthrough in Herbicide Tolerance: Cibus Inc s HT2 Trait Shows Promise Amidst Financial ChallengesIn a significant stride towards enhancing agricultural productivity, Cibus Inc has confirmed the increased tolerance of its second-generation HT2 trait in Canola, introducing a novel herbicide designed specifically f...
|
Clinical Study
September 3, 2025
: The forefront of pediatric immunization strategies is highlighted through Vaxcyte’s recent announcement regarding the advancement of its VAX-31 Infant Phase 2 Dose-Finding Study. With the initial participants now receiving the optimized doses of VAX-31, the study aims to determine the most effective dosing regim...
|
|
|
Company News
|
Business Update
August 20, 2024
BRIDGEWATER, N.J. Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has achieved a significant milestone that promises to enhance clinical practices in the administration of anesthesia. The U.S. Food and Drug Administration (FDA) has granted Abbreviated New Drug Application (ANDA) approval for Amneal s Propofol Injec...
|
Announcement
August 20, 2024
FutureFuel Corp. Undergoes Leadership Changes Amidst Legal Challenges In a significant shift for FutureFuel Corp. (NYSE: FF), a prominent player in the manufacturing of custom and performance chemicals and biofuels, the company has appointed Roeland Polet as its new Chief Executive Officer, effective September 3, 20...
|
Partnership
August 20, 2024
Enhancing Battery Safety and Performance: KULR Teams Up with Amprius TechnologiesIn a compelling move aimed at revolutionizing battery technology for advanced air mobility, KULR Technology Group (NYSE American: KULR) has announced its partnership with Amprius Technologies Inc. (NYSE: AMPX). The two companies will c...
|
|
|
Company News
 Clinical Study
August 20, 2024
|
Company News
 Clinical Study
August 20, 2024
|
Company News
 Contract
August 20, 2024
|
More Company News
|
Announcement
August 20, 2024
|
Clinical Study
August 20, 2024
|
Announcement
August 20, 2024
|
Product Service News
August 20, 2024
|
Product Service News
August 20, 2024
|
Product Service News
August 20, 2024
|
Management Announcement
August 20, 2024
|
Announcement
August 20, 2024
|
Business Update
August 20, 2024
|
Financing Agreement
August 20, 2024
|
|
|
|
Related News
|
Business Update
|
Partnership
|
|
Stocks
|
Clinical Study
|
Business Update
|
Management Announcement
|
|
|
|
Business News
|
|
Business Update
In a significant stride for Voya Financial, the firm has announced a momentous milestone, surpassing $100 billion in assets across multiple employer solutions. This achievement not only underscores Voya s strategic focus on servicing employer needs through Multiple Employer Plans (MEPs), Pooled Employer Plans (PEPs)...
|
|
Product Service News
Actuate Therapeutics to Ring the Nasdaq Opening Bell on August 23, 2024, Marking a New Chapter in Biopharmaceutical Innovation CHICAGO and FORT WORTH, Texas In a significant milestone for the biopharmaceutical community, Actuate Therapeutics, Inc. (NASDAQ: ACTU) is set to ring the Nasdaq Stock Market opening bell ...
|
 Product Service News
The Honest Company Collaborates with Lil Libros in Celebration of Latin American Culture Introduces Limited Edition Diapers, Wipes, and Baby Personal Care Exclusively at Walmart In a move that highlights the enriching tapestry of Latin American culture, The Honest Company has partnered with Lil Libros to intr...
|
 Partnership
In a pivotal move reflecting the increasing importance of cybersecurity in sports management, Juventus Football Club has officially announced Fortinet as its cybersecurity partner. This collaboration symbolizes an ambitious effort by Juventus to reinforce the integrity of its operations within the digital landscape....
|
 Product Service News
In an era where businesses are increasingly looking to leverage technology for competitive advantage, Rackspace Technology is positioning itself as a critical player by delivering innovative solutions that integrate open-source offerings, artificial intelligence, and strategic collaborations. The recent launch of it...
|
Our Most Popular Articles
|
 Partnership
Beam Global and Zero Motorcycles Join Forces to Promote Sustainable Solutions at MotoGP and TEVCON Events In an increasingly environmentally-conscious world, the collaboration between Beam Global and Zero Motorcycles is setting a precedent for sustainability in the motorsports industry. During the upcoming MotoGP an...
|
 Product Service News
Breakthrough in Herbicide Tolerance: Cibus Inc s HT2 Trait Shows Promise Amidst Financial ChallengesIn a significant stride towards enhancing agricultural productivity, Cibus Inc has confirmed the increased tolerance of its second-generation HT2 trait in Canola, introducing a novel herbicide designed specifically f...
|
|
Clinical Study
: The forefront of pediatric immunization strategies is highlighted through Vaxcyte’s recent announcement regarding the advancement of its VAX-31 Infant Phase 2 Dose-Finding Study. With the initial participants now receiving the optimized doses of VAX-31, the study aims to determine the most effective dosing regim...
|
More News
|
 Business Update
BRIDGEWATER, N.J. Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has achieved a significant milestone that promises to enhance clinical practices in the administration of anesthesia. The U.S. Food and Drug Administration (FDA) has granted Abbreviated New Drug Application (ANDA) approval for Amneal s Propofol Injec...
|
 Announcement
FutureFuel Corp. Undergoes Leadership Changes Amidst Legal Challenges In a significant shift for FutureFuel Corp. (NYSE: FF), a prominent player in the manufacturing of custom and performance chemicals and biofuels, the company has appointed Roeland Polet as its new Chief Executive Officer, effective September 3, 20...
|
 Partnership
Enhancing Battery Safety and Performance: KULR Teams Up with Amprius TechnologiesIn a compelling move aimed at revolutionizing battery technology for advanced air mobility, KULR Technology Group (NYSE American: KULR) has announced its partnership with Amprius Technologies Inc. (NYSE: AMPX). The two companies will c...
|
 Clinical Study
The pursuit of effective pain management solutions has led to innovative developments in the pharmaceutical landscape. PainReform Ltd., a clinical-stage specialty pharmaceutical company, has emerged at the forefront of this endeavor with its proprietary formulation, PRF-110, designed to address post-surgical pain, p...
|
 Clinical Study
Pioneering Research: AIM ImmunoTech Reveals Promising Outcomes in Ampligen s Role in Pancreatic Cancer TreatmentAIM ImmunoTech has recently garnered significant attention in both the medical community and investment circles with its latest findings on Ampligen, a promising therapeutic candidate in the treatment of ...
|
 Contract
In a significant development within the defense contracting landscape, Telos Corporation has clinched a prime position on a colossal $12.5 billion Infrastructure Modernization Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded by the United States Air Force. This pivotal agreement signals not just a luc...
|
 Announcement
In recent months, Brunswick Corporation (NYSE: BC), the world’s leading marine technology company, has initiated significant organizational changes and ambitious strategies to pave the way for a more innovative and supportive workplace. These developments not only underscore Brunswick s commitment to advancing mar...
|
 Clinical Study
In the year of Our Lord, Two Thousand and Twenty-Four, as the march of medical science continues to unfold, it is with great fervour that we report developments in the field of pharmacotherapy for individuals afflicted with the malaise of narcolepsy. Avadel Pharmaceuticals plc, a biopharmaceutical entity dedicated t...
|
 Announcement
Gray Media Triumphs with Eight Edward R. Murrow Awards for Journalistic ExcellenceATLANTA, Aug. 20, 2024 Gray Media (Gray) (NYSE: GTN) has announced a landmark achievement in the field of broadcast journalism, as the Radio Television Digital News Association (RTDNA) has bestowed eight National Edward R. Murrow Aw...
|
 Product Service News
Dayforce Leads the Future of Professional Development with Supercharged AI Capabilities By In an era where continuous learning and development are key to professional success, Dayforce has unveiled a transformative solution poised to revolutionize employee training and development. The new Dayforce Learning platfo...
|
 Product Service News
Abercrombie & Fitch Co. (NYSE: ANF), the parent company of Abercrombie & Fitch and Hollister, has made significant strides in broadening its market reach and enhancing its brand profiles with recent launches and partnerships. Hollister Unveils Collegiate Graphics Shop Hollister, a subsidiary of Abercrombie & Fitch ...
|
 Product Service News
AI-Powered Platform Chaintrade Set to Transform Data Intelligence in Capital Markets In an era increasingly defined by the seamless integration of artificial intelligence (AI) into every facet of industry, the capital markets are no exception. On the heels of intensifying interest in the capabilities of machine lear...
|
 Management Announcement
Ekso Bionics Makes Strides with CMS Reimbursement and Launches EksoHealth Personal Program
Ekso Bionics Holdings Inc, a leading exoskeleton technology company, has recently announced the receipt of initial reimbursement from the Centers for Medicare & Medicaid Services (CMS) for its Ekso Indego Personal exoskeleton. This marks a significant milestone for the company as it continues to expand its reach in the healthcare industry.
The CMS reimbursement validates the efficacy and value of Ekso Bionics exoskeleton technology in improving the lives of individuals with mobility limitations. The Ekso Indego Personal is designed to provide assistance to those with spinal cord injuries and other neurological impairments, enabling them to regain mobility and independence.
|
|
Announcement
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR Cones to EMPOWR Revision Knee, Witnesses Revenue SurgeIn a revolutionary stride towards optimizing revision knee surgery, Enovis Corp announced the successful completion of the first surgeries using the newly-integrated EMPOWR Cones with...
|
 Business Update
MADISON, Wis. Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, continues to push the boundaries in cancer early detection and diagnostics, as evidenced by two significant recent announcements. The company recently enrolled the first patient in its Multi-Cancer Earl...
|
 Financing Agreement
GeoVax Labs: A Bold Move in Biotechnology Secures $8.5 Million to Advance Cancer and Infectious Disease Therapies
In a significant development for its growth and future initiatives, GeoVax Labs, Inc. (Nasdaq: GOVX), an Atlanta-based biotechnology company focused on immunotherapy and vaccine developmen...
|
|
|
|
|
